In response to an inaccurate editorial and article about the New York Attorney General's (AG's) agreement with GNC, American Herbal Products Association (AHPA) President Michael McGuffin sent a letter to the editor to highlight that the New York Times failed to report that the AG found no evidence that GNC deviated from the federal current good manufacturing practice (cGMP) rules.
McGuffin stresses that the cGMP rules require, among many other controls, that dietary supplements meet all specifications, including for identity and contaminants.
"Contrary to the original allegation, the Attorney General has now determined that in fact there was no contamination or substitution in the tested GNC products," McGuffin notes.
McGuffin stresses the significance of this oversight and requests the New York Times to correct this omission in both articles. McGuffin also notes that all material facts should be presented because readers deserve to know exactly what the AG found.
View McGuffin's letter to the editor.